COULD AUTOPHAGY-RELATED PROTEINS BE A BIOMARKER IN EARLY PARKINSON'S DISEASE? POTENTIAL NOVEL CSF BIOMARKERS IN PARKINSON'S DISEASE

被引:0
|
作者
Jang, W. [1 ]
Youn, J. [2 ]
机构
[1] Univ Ulsan, Gangneung Asan Hosp, Neurol, Kangnung, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Neurol, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P-096
引用
收藏
页码:E65 / E65
页数:1
相关论文
共 50 条
  • [1] Cerebrospinal Fluid Levels of Autophagy-related Proteins Represent Potentially Novel Biomarkers of Early-Stage Parkinson's Disease
    Youn, Jinyoung
    Lee, Sang-Bin
    Lee, Hyo Sang
    Yang, Hyun Ok
    Park, Jinse
    Kim, Ji Sun
    Oh, Eungseok
    Park, Suyeon
    Jang, Wooyoung
    SCIENTIFIC REPORTS, 2018, 8
  • [2] Cerebrospinal Fluid Levels of Autophagy-related Proteins Represent Potentially Novel Biomarkers of Early-Stage Parkinson’s Disease
    Jinyoung Youn
    Sang-Bin Lee
    Hyo Sang Lee
    Hyun Ok Yang
    Jinse Park
    Ji Sun Kim
    Eungseok Oh
    Suyeon Park
    Wooyoung Jang
    Scientific Reports, 8
  • [3] Alteration of autophagy-related proteins in peripheral blood mononuclear cells of patients with Parkinson's disease
    Miki, Yasuo
    Shimoyama, Shuji
    Kon, Tomoya
    Ueno, Tatsuya
    Hayakari, Ryo
    Tanji, Kunikazu
    Matsumiya, Tomoh
    Tsushima, Eiki
    Mori, Fumiaki
    Wakabayashi, Koichi
    Tomiyama, Masahiko
    NEUROBIOLOGY OF AGING, 2018, 63 : 33 - 43
  • [4] Update on CSF Biomarkers in Parkinson's Disease
    Kwon, Eun Hae
    Tennagels, Sabrina
    Gold, Ralf
    Gerwert, Klaus
    Beyer, Leon
    Toenges, Lars
    BIOMOLECULES, 2022, 12 (02)
  • [5] CSF and blood biomarkers for Parkinson's disease
    Parnetti, Lucilla
    Gaetani, Lorenzo
    Eusebi, Paolo
    Paciotti, Silvia
    Hansson, Oskar
    El-Agnaf, Omar
    Mollenhauer, Brit
    Blennow, Kaj
    Calabresi, Paolo
    LANCET NEUROLOGY, 2019, 18 (06): : 573 - 586
  • [6] CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
    Ju-Hee Kang
    Brit Mollenhauer
    Christopher S. Coffey
    Jon B. Toledo
    Daniel Weintraub
    Douglas R. Galasko
    David J. Irwin
    Vivianna Van Deerlin
    Alice S. Chen-Plotkin
    Chelsea Caspell-Garcia
    Teresa Waligórska
    Peggy Taylor
    Nirali Shah
    Sarah Pan
    Pawel Zero
    Mark Frasier
    Kenneth Marek
    Karl Kieburtz
    Danna Jennings
    Caroline M. Tanner
    Tanya Simuni
    Andrew Singleton
    Arthur W. Toga
    Sohini Chowdhury
    John Q. Trojanowski
    Leslie M. Shaw
    Acta Neuropathologica, 2016, 131 : 935 - 949
  • [7] CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study
    Kang, Ju-Hee
    Mollenhauer, Brit
    Coffey, Christopher S.
    Toledo, Jon B.
    Weintraub, Daniel
    Galasko, Douglas R.
    Irwin, David J.
    Van Deerlin, Vivianna
    Chen-Plotkin, Alice S.
    Caspell-Garcia, Chelsea
    Waligorska, Teresa
    Taylor, Peggy
    Shah, Nirali
    Pan, Sarah
    Zero, Pawel
    Frasier, Mark
    Marek, Kenneth
    Kieburtz, Karl
    Jennings, Danna
    Tanner, Caroline M.
    Simuni, Tanya
    Singleton, Andrew
    Toga, Arthur W.
    Chowdhury, Sohini
    Trojanowski, John Q.
    Shaw, Leslie M.
    ACTA NEUROPATHOLOGICA, 2016, 131 (06) : 935 - 949
  • [8] Potential biomarkers of Parkinson's disease
    Gerlach, M.
    Hendrichz, A.
    Hueber, R.
    Jost, W.
    Riederers, P.
    Winklers, J.
    Woitalla, D.
    AKTUELLE NEUROLOGIE, 2007, 34 : S28 - S30
  • [9] Measurement of CSF proteins suggested by gene expression studies as potential Parkinson's disease biomarkers
    Loeffler, D.
    LeWitt, P.
    Aasly, J.
    Smith, L.
    Coffey, M.
    MOVEMENT DISORDERS, 2015, 30 : S41 - S41
  • [10] MicroRNAs as a potential biomarker of Parkinson's disease
    Ardashirova, N.
    Protopopova, A.
    Abramycheva, N.
    Fedotova, E.
    Illarioshkin, S.
    MOVEMENT DISORDERS, 2021, 36 : S329 - S330